News_banner

CityU’s huge success at Inventions Geneva Evaluation Days 2022; top among local universities for the second year

CityU research

Researchers at City University of Hong Kong (CityU) received tremendous accolades at Inventions Geneva Evaluation Days (IGED) 2022 by winning a total of 22 awards, the highest number among local institutions for two years in a row, including one Gold Medal with Congratulations of the Jury, six Gold Medals, 13 Silver Medals and two Bronze Medals. Their success keenly demonstrates CityU’s outstanding research achievements.

Professor Way Kuo, CityU President, is delighted with the results. “CityU promotes knowledge transfer and advocates ‘the integration of teaching and research’ to align with world-class universities. CityU’s world-class faculty contributes by converting outstanding research into commercial products,” he said.

Leading innopreneurship, CityU announced in March 2021 the launch of a large-scale flagship innovation and entrepreneurship programme, HK Tech 300. With an allocation of HK$500 million, the programme aims to assist CityU’s students, faculty and staff, alumni as well as members of the public to establish 300 start-ups in three years. It is the largest university-based entrepreneurship programme in Asia in terms of the amount of investment and scale. 

Among the winning teams in IGED 2022 are starts-up under HK Tech 300 and the Technology Start-up Support Scheme for Universities (TSSSU) at CityU.

In fact, CityU’s teaching and research team has been recognised internationally. CityU is ranked 51st in the top 100 worldwide universities granted US utility patents by the National Academy of Inventors 2020, making us top among local universities for the 5th consecutive year.

In view of the pandemic, IGED is the virtual edition of the International Exhibition of Inventions of Geneva, which is the world’s most important annual event devoted exclusively to inventions.

For details of CityU's award-winning projects, please refer to the attachment.

Read the original news.

Sitemap

arrow